(1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
Details for Australian Patent Application No. 2003223627 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/373,731 18.04.02 US
11 December 2003 Application Open to Public Inspection
Published as AU-B-2003223627
12 October 2006 Application Accepted
Published as AU-B-2003223627
4 January 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 28 Nov 2006. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060
26 April 2007 Standard Patent Sealed
24 May 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 28 Nov 2006
10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003223628-System for frontal display of objects
2003223626-Multi-layered macromolecules and methods for their use
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser